Trends in P2Y12 receptor inhibitor use and adherence after percutaneous coronary intervention, 2008-2016
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Research brief (Leonard Davis Institute of Health Economics)
- Author(s):
- Dayoub, Elias J., author Seigerman, Matthew, author Tuteja, Sony, author Kobayashi, Taisei, author Kolansky, Daniel, author Giri, Jay, author Groeneveld, Peter, author
- Contributor(s):
- Leonard Davis Institute of Health Economics, issuing body.
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Medication Adherence -- statistics & numerical data Percutaneous Coronary Intervention Purinergic P2Y Receptor Antagonists -- therapeutic use Socioeconomic Factors Drug Costs Drugs, Generic -- economics Drugs, Generic -- therapeutic use Platelet Aggregation Inhibitors -- economics Platelet Aggregation Inhibitors -- therapeutic use Purinergic P2Y Receptor Antagonists -- economics Social Determinants of Health Humans United States
- Genre(s):
- Technical Report
- Abstract:
- Key Findings. Post-angioplasty, patient adherence to recommended antiplatelet therapy decreased when newer, more expensive drugs were introduced. From 2008-2016, as the use of newer agents increased, the proportion of patients not filling any antiplatelet prescription within 30 days of discharge increased from 6.4% to 19.1%. In the subsequent 12 months, the newer drugs were associated with higher patient costs and lower adherence to recommended therapy.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
- 1 online resource (1 PDF file (2 unnumbered pages))
- Illustrations:
- Illustrations and Portraits
- NLM Unique ID:
- 101731629 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101731629